Treventis was well represented at the Alzheimer Association International Conference, running from Jul 27-31, 2020 (originally scheduled for Amsterdam, the Netherlands, and converted to virtual format due to COVID-19). CEO Christopher Barden, VP Research Marcia Taylor, CSO Mark Reed, and Chief Medical Officer Dr. Donald Weaver were delegates at the conference, the preeminent global annual gathering of Alzheimer’s researchers.